<?xml version="1.0" encoding="utf-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:types="http://xbrl.frc.org.uk/general/2014-09-01/types" xmlns:uk-ref="http://xbrl.frc.org.uk/general/2014-09-01/ref" xmlns:common="http://xbrl.frc.org.uk/general/2014-09-01/common" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:curr="http://xbrl.frc.org.uk/cd/2014-09-01/currencies" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:countries="http://xbrl.frc.org.uk/cd/2014-09-01/countries" xmlns:lang="http://xbrl.frc.org.uk/cd/2014-09-01/languages" xmlns:bus="http://xbrl.frc.org.uk/cd/2014-09-01/business" xmlns:accrep="http://xbrl.frc.org.uk/reports/2014-09-01/accrep" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:aurep="http://xbrl.frc.org.uk/reports/2014-09-01/aurep" xmlns:Q1="http://xbrl.org/2005/xbrldt" xmlns:direp="http://xbrl.frc.org.uk/reports/2014-09-01/direp" xmlns:core="http://xbrl.frc.org.uk/fr/2014-09-01/core" xmlns:FRS-102="http://xbrl.frc.org.uk/FRS-102/2014-09-01" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2010-04-20" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="application/xhtml+xml; charset=UTF-8" http-equiv="Content-Type" /><title>LARKIN_OPHTHALMOLOGY_LIMI - Accounts</title><style type="text/css">@page land { size:landscape; }@page port { size:portrait; }.pageFirst { page-break-after:always;  background-color:white;    border-top:1px solid black;  border-bottom:1px solid black;    border-left:1px solid black;    border-right:1px solid black;   } .portraitPage {    page:port;  width:21cm; height:29.7cm; page-break-after:always; background-color:white; border-top:1px solid black; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; position:relative; } .landscapePage {  page:land;  width:29.7cm; height:21cm; page-break-after:always; background-color:white; border-top:1px solid black; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; position:relative; } a.tooltip {color:black;text-decoration:none}a.tooltip span{display:none}a.tooltip:hover span{display:inline;position:absolute;z-index:5002;background:#ffffff}a.anchor {color:blue;}a.tooltipRTF {color:black;text-decoration:none;display:none}span:hover a.tooltipRTF {display:block;position:absolute;background:#ffffff}span.tooltipRTFtext {position:absolute;left:10;width:200;border:1pt solid black;text-align:left;font-weight:normal;z-index:5002;bottom:20;font-family:Arial;font-size:9;background-color:#FFFFCC; }.c,.crn,.cjn,.cln,.ccn,.crb,.cjb,.clb,.ccb,.crni,.cjni,.clni,.ccni,.crbi,.cjbi,.clbi,.ccbi{position:absolute;word-wrap:break-word}.crn,.cjn,.cln,.ccn,.crni,.cjni,.clni,.ccni{font-weight:normal}.crb,.clb,.cjb,.ccb,.crbi,.cjbi,.clbi,.ccbi{font-weight:bold}.crni,.cjni,.clni,.ccni,.crbi,.cjbi,.clbi,.ccbi{font-style:italic}.crn,.crb,.crni,.crbi{text-align:right}.cln,.clb,.clni,.clbi{text-align:left}.ccn,.ccb,.ccni,.ccbi{text-align:center}.cjn,.cjb,.cjni,.cjbi{text-align:justify}.fn0{font-size:0px}.fn1{font-size:10.4px;font-family:Arial}.fn2{font-size:15.2px;font-family:Arial}.fn3{font-size:12.8px;font-family:Arial}.fn4{font-size:6.4px;font-family:Arial}.fn5{font-size:9.6px;font-family:Arial}.fn6{font-size:0px;font-family:Arial}.fn7{font-size:8.5px;font-family:Arial}.sln{border-top:1px solid black}.dln{border-top:4px double black}.u{text-decoration:underline}ul,li{ margin-top:0px;margin-bottom:0px;margin-right:0px;margin-left:8px;   padding-top:0px;padding-bottom:0px;padding-right:0px;padding-left:8px;} </style></head><body xml:lang="en" style="background-color:white"><div class="pageFirst" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="crb fn1" style="top:52.31pt;left:43.61pt;width:420.55pt;"><ix:nonNumeric contextRef="C" name="bus:CountryFormationOrIncorporation"></ix:nonNumeric>Company Registration No. <ix:nonNumeric contextRef="C" name="bus:UKCompaniesHouseRegisteredNumber">07199788</ix:nonNumeric> (England and Wales)</div><div class="ccb fn2" style="top:162.17pt;left:46.61pt;width:420.55pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">LARKIN OPHTHALMOLOGY LIMITED</ix:nonNumeric></div><div class="ccb fn2" style="top:188.45pt;left:46.61pt;width:420.55pt;">UNAUDITED FINANCIAL STATEMENTS</div><div class="ccb fn2" style="top:214.74pt;left:46.61pt;width:420.55pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="ccb fn2" style="top:241.12pt;left:46.61pt;width:420.55pt;">PAGES FOR FILING WITH REGISTRAR</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">LARKIN OPHTHALMOLOGY LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">CONTENTS</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:98.82pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn1" style="top:123.45pt;left:409.6pt;width:60.79pt;">Page</div><div class="cln fn1" style="top:156.46pt;left:46.61pt;width:362.98pt;">Balance sheet</div><div class="cln fn1" style="top:156.46pt;left:409.6pt;width:57.79pt;">1</div><div class="cln fn1" style="top:200.49pt;left:46.61pt;width:362.98pt;">Notes to the financial statements</div><div class="cln fn1" style="top:200.49pt;left:409.6pt;width:57.79pt;">2 - 6</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">LARKIN OPHTHALMOLOGY LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">BALANCE SHEET </div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">AS AT <div style="display:inline">30 JUNE 2019<div style="display:none"><ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="bus:BalanceSheetDate">30 June 2019</ix:nonNumeric></div></div></div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 1 -</div><div class="clb fn1" style="top:122.11pt;left:297.71pt;width:59.56pt;">2019</div><div class="clb fn1" style="top:122.11pt;left:410.83pt;width:59.55pt;">2018</div><div class="ccb fn1" style="top:133.12pt;left:206.98pt;width:37.17pt;">Notes</div><div class="crb fn1" style="top:133.12pt;left:238.15pt;width:59.56pt;">£</div><div class="crb fn1" style="top:133.12pt;left:294.71pt;width:59.56pt;">£</div><div class="crb fn1" style="top:133.12pt;left:351.27pt;width:59.55pt;">£</div><div class="crb fn1" style="top:133.12pt;left:407.83pt;width:59.55pt;">£</div><div class="cln fn6" style="top:133.12pt;left:468.03pt;width:0.65pt;"></div><div class="clb fn1" style="top:155.13pt;left:46.61pt;width:367.21pt;">Fixed assets</div><div class="cln fn1" style="top:166.14pt;left:46.61pt;width:160.36pt;">Tangible assets</div><div class="ccb fn1" style="top:166.14pt;left:206.98pt;width:37.17pt;">3</div><div class="crn fn1" style="top:166.14pt;left:297.71pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">1,008</ix:nonFraction></div><div class="crn fn1" style="top:166.14pt;left:410.83pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" name="core:PropertyPlantEquipment">544</ix:nonFraction></div><div class="clb fn1" style="top:188.15pt;left:46.61pt;width:197.53pt;">Current assets</div><div class="cln fn1" style="top:199.16pt;left:46.61pt;width:160.36pt;">Debtors</div><div class="ccb fn1" style="top:199.16pt;left:206.98pt;width:37.17pt;">4</div><div class="crn fn1" style="top:199.16pt;left:241.15pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Debtors">31,585</ix:nonFraction></div><div class="crn fn1" style="top:199.16pt;left:354.27pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Debtors">66,101</ix:nonFraction></div><div class="cln fn1" style="top:210.16pt;left:46.61pt;width:160.36pt;">Cash at bank and in hand</div><div class="crn fn1" style="top:210.16pt;left:241.15pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CashBankOnHand">1,178,877</ix:nonFraction></div><div class="crn fn1" style="top:210.16pt;left:354.27pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CashBankOnHand">1,055,157</ix:nonFraction></div><div class="cln fn0 sln" style="top:226.01pt;left:260.26pt;width:37.45pt;"></div><div class="cln fn0 sln" style="top:226.01pt;left:373.38pt;width:37.45pt;"></div><div class="crn fn1" style="top:232.17pt;left:241.15pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CurrentAssets">1,210,462</ix:nonFraction></div><div class="crn fn1" style="top:232.17pt;left:354.27pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CurrentAssets">1,121,258</ix:nonFraction></div><div class="clb fn1" style="top:243.18pt;left:46.61pt;width:163.36pt;">Creditors: amounts falling due within one year</div><div class="ccb fn1" style="top:252.86pt;left:206.98pt;width:37.17pt;">5</div><div class="crn fn1" style="top:252.86pt;left:243.95pt;width:56.56pt;">(<ix:nonFraction contextRef="B_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">69,392</ix:nonFraction>)</div><div class="crn fn1" style="top:252.86pt;left:357.07pt;width:56.55pt;">(<ix:nonFraction contextRef="E_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">76,991</ix:nonFraction>)</div><div class="cln fn0 sln" style="top:268.7pt;left:260.26pt;width:37.45pt;"></div><div class="cln fn0 sln" style="top:268.7pt;left:373.38pt;width:37.45pt;"></div><div class="clb fn1" style="top:274.87pt;left:46.61pt;width:254.09pt;">Net current assets</div><div class="crn fn1" style="top:274.87pt;left:297.71pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:NetCurrentAssetsLiabilities">1,141,070</ix:nonFraction></div><div class="crn fn1" style="top:274.87pt;left:410.83pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:NetCurrentAssetsLiabilities">1,044,267</ix:nonFraction></div><div class="cln fn0 sln" style="top:290.71pt;left:316.82pt;width:37.45pt;"></div><div class="cln fn0 sln" style="top:290.71pt;left:429.94pt;width:37.45pt;"></div><div class="clb fn1" style="top:296.88pt;left:46.61pt;width:197.53pt;">Total assets less current liabilities</div><div class="crn fn1" style="top:296.88pt;left:297.71pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalAssetsLessCurrentLiabilities">1,142,078</ix:nonFraction></div><div class="crn fn1" style="top:296.88pt;left:410.83pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalAssetsLessCurrentLiabilities">1,044,811</ix:nonFraction></div><div class="cln fn0 dln" style="top:312.73pt;left:316.82pt;width:37.45pt;"></div><div class="cln fn0 dln" style="top:312.73pt;left:429.94pt;width:37.45pt;"></div><div class="clb fn1" style="top:329.9pt;left:46.61pt;width:163.36pt;">Capital and reserves</div><div class="cln fn1" style="top:340.91pt;left:46.61pt;width:160.36pt;">Called up share capital</div><div class="ccb fn1" style="top:340.91pt;left:206.98pt;width:37.17pt;">6</div><div class="crn fn1" style="top:340.91pt;left:297.71pt;width:56.56pt;"><ix:nonFraction contextRef="B_HO_HP" decimals="0" scale="0" unitRef="GBP" name="core:Equity">100</ix:nonFraction></div><div class="crn fn1" style="top:340.91pt;left:410.83pt;width:56.55pt;"><ix:nonFraction contextRef="E_HO_HP" decimals="0" scale="0" unitRef="GBP" name="core:Equity">100</ix:nonFraction></div><div class="cln fn1" style="top:351.92pt;left:46.61pt;width:160.36pt;">Profit and loss reserves</div><div class="ccb fn1" style="top:351.92pt;left:206.98pt;width:37.17pt;"></div><div class="crn fn1" style="top:351.92pt;left:297.71pt;width:56.56pt;"><ix:nonFraction contextRef="B_HO_HQ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">1,141,978</ix:nonFraction></div><div class="crn fn1" style="top:351.92pt;left:410.83pt;width:56.55pt;"><ix:nonFraction contextRef="E_HO_HQ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">1,044,711</ix:nonFraction></div><div class="cln fn0 sln" style="top:367.76pt;left:316.82pt;width:37.45pt;"></div><div class="cln fn0 sln" style="top:367.76pt;left:429.94pt;width:37.45pt;"></div><div class="clb fn1" style="top:373.93pt;left:46.61pt;width:197.53pt;">Total equity</div><div class="crn fn1" style="top:373.93pt;left:297.71pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">1,142,078</ix:nonFraction></div><div class="crn fn1" style="top:373.93pt;left:410.83pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">1,044,811</ix:nonFraction></div><div class="cln fn0 dln" style="top:389.77pt;left:316.82pt;width:37.45pt;"></div><div class="cln fn0 dln" style="top:389.77pt;left:429.94pt;width:37.45pt;"></div><div class="cln" style="top:407pt;left:47pt;width:421pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:EntityHasTakenExemptionUnderCompaniesActInNotPublishingItsOwnProfitLossAccountTruefalse"><span class="fn1"><ix:exclude>The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.</ix:exclude><span style="display:none">true</span></span></ix:nonNumeric></p></div><div class="cln" style="top:439pt;left:47pt;width:421pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatCompanyEntitledToExemptionFromAuditUnderSection477CompaniesAct2006RelatingToSmallCompanies"><span class="fn1">For the financial year ended 30 June 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.</span></ix:nonNumeric></p></div><div class="cln" style="top:470pt;left:47pt;width:421pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatDirectorsAcknowledgeTheirResponsibilitiesUnderCompaniesAct"><span class="fn1">The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.</span></ix:nonNumeric></p></div><div class="cln" style="top:502pt;left:47pt;width:421pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatMembersHaveNotRequiredCompanyToObtainAnAudit" continuedAt="C_IO_0"><span class="fn1">T</span></ix:nonNumeric><span class="fn1"></span><ix:continuation id="C_IO_0" continuedAt="C_IO_1"><span class="fn1">he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IO_1"><span class="fn1">.</span></ix:continuation></p></div><div class="cln" style="top:533pt;left:47pt;width:421pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatAccountsHaveBeenPreparedInAccordanceWithProvisionsSmallCompaniesRegime"><span class="fn1">These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.</span></ix:nonNumeric></p></div><div class="cjn fn1" style="top:564.98pt;left:46.61pt;width:420.77pt;">The financial statements were approved by the board of directors and authorised for issue on <ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="core:DateAuthorisationFinancialStatementsForIssue">16 March 2020</ix:nonNumeric> and are signed on its behalf by:</div><div class="cln fn1" style="top:618.69pt;left:46.61pt;width:420.77pt;"><ix:nonNumeric contextRef="C_HR_HS" name="core:DirectorSigningFinancialStatements"></ix:nonNumeric>Mr D F P Larkin</div><div class="clb fn1" style="top:629.69pt;left:46.61pt;width:423.77pt;">Director</div><div class="clb fn1" style="top:651.71pt;left:46.61pt;width:423.77pt;">Company Registration No. 07199788</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">LARKIN OPHTHALMOLOGY LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS </div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 2 -</div><div class="clb fn1" style="top:122.11pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn1" style="top:122.11pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="cln fn6" style="top:122.11pt;left:466.79pt;width:0.65pt;"></div><div class="clb fn1" style="top:144.12pt;left:67.73pt;width:401.41pt;">Company information</div><div class="cln" style="top:155pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Larkin Ophthalmology Limited is a</span><span class="fn1"> private </span><span class="fn1">company</span><span class="fn1"> limited by shares</span><span class="fn1"> incorporated in England and Wales.</span><span class="fn1"> </span><span class="fn1">The registered office is</span><span class="fn1"> 93 Tabernacle Street, London, England, EC2A 4BA.</span></p></div><div class="clb fn1" style="top:186.83pt;left:46.61pt;width:24.12pt;">1.1</div><div class="clb fn1" style="top:186.83pt;left:67.73pt;width:401.41pt;">Accounting convention</div><div class="cln" style="top:198pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.</span></p></div><div class="cln" style="top:258pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">The financial statements are prepared in</span><span class="fn1"> sterling</span><span class="fn1">, which is the functional currency of the company. </span><span class="fn1">Monetary a</span><span class="fn1">mounts </span><span class="fn1">in these financial statements are </span><span class="fn1">rounded to the nearest £.</span></p></div><div class="cln" style="top:290pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.</span></p></div><div class="clb fn1" style="top:330.98pt;left:46.61pt;width:24.12pt;">1.2</div><div class="clb fn1" style="top:330.98pt;left:67.73pt;width:401.41pt;">Turnover</div><div class="cln" style="top:342pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:RevenueRecognitionPolicy" continuedAt="C_IP_0"><span class="fn1">Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business</span></ix:nonNumeric><span class="fn1"></span><ix:continuation id="C_IP_0" continuedAt="C_IP_1"><span class="fn1">, and</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IP_1" continuedAt="C_IP_2"><span class="fn1"> is shown net of VAT and other sales related taxes</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IP_2" continuedAt="C_IP_3"><span class="fn1">. </span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IP_3" continuedAt="C_IP_4"><span class="fn1">The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_IP_4"><span class="fn1">When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.</span></ix:continuation></p></div><div class="cln" style="top:422pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs.  Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that </span><span class="fn1">it is probable will be</span><span class="fn1"> recover</span><span class="fn1">ed</span><span class="fn1">.</span></p></div><div class="clb fn1" style="top:492.06pt;left:46.61pt;width:24.12pt;">1.3</div><div class="clb fn1" style="top:492.06pt;left:67.73pt;width:401.41pt;">Intangible fixed assets - goodwill</div><div class="cln" style="top:503pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C_HU_HV" name="core:IntangibleAssetsPolicy" continuedAt="C_IQ_0"><span class="fn1">Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated</span></ix:nonNumeric><span class="fn1"></span><ix:continuation id="C_IQ_0" continuedAt="C_IQ_1"><span class="fn1"> amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is </span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IQ_1" continuedAt="C_IQ_2"><span class="fn1">10 years</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IQ_2" continuedAt="C_IQ_3"><span class="fn1">. </span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_IQ_3"><span class="fn1">For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.</span></ix:continuation></p></div><div class="clb fn1" style="top:621.65pt;left:46.61pt;width:24.12pt;">1.4</div><div class="clb fn1" style="top:621.65pt;left:67.73pt;width:401.41pt;">Tangible fixed assets</div><div class="cln" style="top:633pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:DescriptionMeasurementBasisForPropertyPlantEquipment" continuedAt="C_IR_0"><span class="fn1">Tangible fixed assets </span></ix:nonNumeric><span class="fn1"></span><ix:continuation id="C_IR_0"><span class="fn1">are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.</span></ix:continuation></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">LARKIN OPHTHALMOLOGY LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn1" style="top:121.45pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn1" style="top:121.45pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="crb fn1" style="top:121.45pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 3 -</div><div class="cln" style="top:144pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Justify;"><ix:nonNumeric contextRef="C" name="core:DescriptionDepreciationMethodForPropertyPlantEquipment"><span class="fn1">Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:</span></ix:nonNumeric></p></div><div class="cln fn1" style="top:175.6pt;left:67.73pt;width:172.16pt;">Fixtures, fittings &amp; equipment</div><div class="cln fn1" style="top:175.6pt;left:239.9pt;width:227.49pt;"><ix:nonNumeric contextRef="C_GX_HY" name="core:DescriptionDepreciationMethodForPropertyPlantEquipment">25% on net book value</ix:nonNumeric></div><div class="cln fn1" style="top:186.61pt;left:67.73pt;width:172.16pt;">Computer equipment</div><div class="cln fn1" style="top:186.61pt;left:239.9pt;width:227.49pt;"><ix:nonNumeric contextRef="C_GX_HZ" name="core:DescriptionDepreciationMethodForPropertyPlantEquipment">25% on net book value</ix:nonNumeric></div><div class="cln" style="top:209pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and </span><span class="fn1">is credited or charged to profit or loss</span><span class="fn1">.</span></p></div><div class="clb fn1" style="top:240.1pt;left:46.61pt;width:24.12pt;">1.5</div><div class="clb fn1" style="top:240.1pt;left:67.73pt;width:401.41pt;">Impairment of fixed assets</div><div class="cln" style="top:251pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">At each reporting </span><span class="fn1">period </span><span class="fn1">end date, the </span><span class="fn1">company </span><span class="fn1">reviews the carrying amounts of its tangible</span><span class="fn1"> and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company </span><span class="fn1">estimates the recoverable amount of the cash-generating unit to which the asset belongs.</span></p></div><div class="cln" style="top:321pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.</span></p></div><div class="cln" style="top:420pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) </span><span class="fn1">in </span><span class="fn1">prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.</span></p></div><div class="clb fn1" style="top:500.4pt;left:46.61pt;width:24.12pt;">1.6</div><div class="clb fn1" style="top:500.4pt;left:67.73pt;width:401.41pt;">Cash and cash equivalents</div><div class="cln" style="top:511pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:CashCashEquivalentsPolicy" continuedAt="C_IS_0"><span class="fn1">Cash and cash equivalents</span></ix:nonNumeric><span class="fn1"> </span><ix:continuation id="C_IS_0" continuedAt="C_IS_1"><span class="fn1">are basic financial assets</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IS_1" continuedAt="C_IS_2"><span class="fn1"> and</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IS_2"><span class="fn1"> include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.</span></ix:continuation></p></div><div class="clb fn1" style="top:552.57pt;left:46.61pt;width:24.12pt;">1.7</div><div class="clb fn1" style="top:552.57pt;left:67.73pt;width:401.41pt;">Financial instruments</div><div class="cln" style="top:563pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:FinancialInstrumentsClassificationPolicy" continuedAt="C_IT_0"><span class="fn1">The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. </span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_IT_0" continuedAt="C_IT_1"><span class="fn1">Financial instruments are recognised in the company&apos;s balance sheet when the company becomes party to the contractual provisions of the instrument.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_IT_1" continuedAt="C_IT_2"><span class="fn1">Financial assets and liabilities are offset</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IT_2" continuedAt="C_IT_3"><span class="fn1">, with</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IT_3" continuedAt="C_IT_4"><span class="fn1"> the net amounts presented in the financial statements</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IT_4" continuedAt="C_IT_5"><span class="fn1">,</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IT_5"><span class="fn1"> when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.</span></ix:continuation></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">LARKIN OPHTHALMOLOGY LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn1" style="top:121.45pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn1" style="top:121.45pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="crb fn1" style="top:121.45pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 4 -</div><div class="clbi fn1" style="top:144.02pt;left:67.73pt;width:344.85pt;">Basic financial assets</div><div class="cln" style="top:155pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest</span><span class="fn1"> </span><span class="fn1">method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.</span><span class="fn1"> Financial assets classified as receivable within one year are not amortised.</span></p></div><div class="clbi fn1" style="top:215.32pt;left:67.73pt;width:401.41pt;">Classification of financial liabilities</div><div class="cln" style="top:226pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.</span></p></div><div class="clbi fn1" style="top:267.27pt;left:67.73pt;width:401.41pt;">Basic financial liabilities</div><div class="cln" style="top:278pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Basic financial liabilities, including creditors, bank loans, loans from</span><span class="fn1"> </span><span class="fn1">fellow group companies and preference shares that are classified as debt, are</span><span class="fn1"> </span><span class="fn1">initially recognised at transaction price unless the arrangement constitutes a</span><span class="fn1"> </span><span class="fn1">financing transaction, where the debt instrument is measured at the present value of</span><span class="fn1"> </span><span class="fn1">the future </span><span class="fn1">paymen</span><span class="fn1">ts discounted at a market rate of interest.</span><span class="fn1"> Financial liabilities classified as payable within one year are not amortised.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Debt instruments are subsequently carried at amortised cost, using the effective</span><span class="fn1"> </span><span class="fn1">interest rate method.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Trade creditors</span><span class="fn1"> are obligations to pay for goods or services that have been acquired</span><span class="fn1"> </span><span class="fn1">in the ordinary course of business from suppliers. A</span><span class="fn1">m</span><span class="fn1">ounts payable are classified as</span><span class="fn1"> </span><span class="fn1">current liabilities if payment is due within one year or less. If not, they are presented</span><span class="fn1"> </span><span class="fn1">as non-current liabilities. Trade creditors are recognised initially at transaction price</span><span class="fn1"> </span><span class="fn1">and subsequently measured at amortised cost using the effective interest method.</span></p></div><div class="clb fn1" style="top:406.44pt;left:46.61pt;width:24.12pt;">1.8</div><div class="clb fn1" style="top:406.44pt;left:67.73pt;width:401.41pt;">Equity instruments</div><div class="cln" style="top:417pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.</span></p></div><div class="clb fn1" style="top:458.6pt;left:46.61pt;width:24.12pt;">1.9</div><div class="clb fn1" style="top:458.6pt;left:67.73pt;width:401.41pt;">Taxation</div><div class="cln" style="top:470pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Justify;"><ix:nonNumeric contextRef="C" name="core:TaxPolicy"><span class="fn1">The tax expense represents the sum of the tax currently payable and deferred tax.</span></ix:nonNumeric></p></div><div class="clbi fn1" style="top:491.3pt;left:67.73pt;width:401.41pt;">Current tax</div><div class="cln" style="top:502pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:CurrentIncomeTaxPolicy" continuedAt="C_IU_0"><span class="fn1">The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The </span></ix:nonNumeric><span class="fn1"></span><ix:continuation id="C_IU_0" continuedAt="C_IU_1"><span class="fn1">company’s </span></ix:continuation><span class="fn1"></span><ix:continuation id="C_IU_1"><span class="fn1">liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.</span></ix:continuation></p></div><div class="clbi fn1" style="top:562.6pt;left:67.73pt;width:401.41pt;">Deferred tax</div><div class="cln" style="top:573pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:DeferredTaxPolicy" continuedAt="C_IV_0"><span class="fn1">Deferred tax is not recognised in respect of all timing differences that have originated but not reversed at the balance sheet date which are immaterial.</span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_IV_0"><span class="fn1">Deferred tax asset is not recognised as it is not probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">LARKIN OPHTHALMOLOGY LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn1" style="top:121.45pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn1" style="top:121.45pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="crb fn1" style="top:121.45pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 5 -</div><div class="clb fn1" style="top:144.12pt;left:46.61pt;width:24.12pt;">1.10</div><div class="clb fn1" style="top:144.12pt;left:67.73pt;width:401.41pt;">Employee benefits</div><div class="cln" style="top:155pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:EmployeeBenefitsPolicy" continuedAt="C_IW_0"><span class="fn1">The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.  </span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_IW_0" continuedAt="C_IW_1"><span class="fn1">The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_IW_1"><span class="fn1">Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.</span></ix:continuation></p></div><div class="clb fn1" style="top:244.68pt;left:46.61pt;width:24.12pt;">1.11</div><div class="clb fn1" style="top:244.68pt;left:67.73pt;width:401.41pt;">Retirement benefits</div><div class="cln" style="top:256pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Justify;"><ix:nonNumeric contextRef="C" name="core:DefinedContributionPensionsPolicy"><span class="fn1">Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.</span></ix:nonNumeric></p></div><div class="clb fn1" style="top:277.49pt;left:46.61pt;width:24.12pt;">2</div><div class="clb fn1" style="top:277.49pt;left:67.73pt;width:402.65pt;">Employees</div><div class="cln" style="top:300pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">The average monthly number of persons (including directors) employed by the company during the year was 3 (2018 - 3).</span></p></div><div class="clb fn1" style="top:331.2pt;left:46.61pt;width:24.12pt;">3</div><div class="clb fn1" style="top:331.2pt;left:67.73pt;width:402.65pt;">Tangible fixed assets</div><div class="crb fn7" style="top:342.96pt;left:315.23pt;width:52.72pt;">Fixtures, fittings &amp; equipment</div><div class="crb fn7" style="top:342.96pt;left:364.95pt;width:52.72pt;">Computer equipment</div><div class="crb fn7" style="top:342.96pt;left:414.68pt;width:52.71pt;">Total</div><div class="crb fn1" style="top:368.88pt;left:315.23pt;width:52.72pt;">£</div><div class="crb fn1" style="top:368.88pt;left:364.95pt;width:52.72pt;">£</div><div class="crb fn1" style="top:368.88pt;left:414.68pt;width:52.71pt;">£</div><div class="cln fn6" style="top:368.88pt;left:468.03pt;width:0.65pt;"></div><div class="clb fn1" style="top:379.88pt;left:67.73pt;width:402.65pt;">Cost</div><div class="cln fn1" style="top:390.89pt;left:67.73pt;width:250.5pt;">At 1 July 2018</div><div class="crn fn1" style="top:390.89pt;left:318.23pt;width:49.72pt;"><ix:nonFraction contextRef="A_GX_HY" decimals="0" scale="0" unitRef="GBP" name="core:PropertyPlantEquipmentGrossCost">789</ix:nonFraction></div><div class="crn fn1" style="top:390.89pt;left:367.95pt;width:49.72pt;"><ix:nonFraction contextRef="A_GX_HZ" decimals="0" scale="0" unitRef="GBP" name="core:PropertyPlantEquipmentGrossCost">629</ix:nonFraction></div><div class="crn fn1" style="top:390.89pt;left:417.68pt;width:49.71pt;"><ix:nonFraction contextRef="A" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">1,418</ix:nonFraction></div><div class="cln fn1" style="top:401.9pt;left:67.73pt;width:250.5pt;">Additions</div><div class="crn fn1" style="top:401.9pt;left:318.23pt;width:49.72pt;">-</div><div class="crn fn1" style="top:401.9pt;left:367.95pt;width:49.72pt;"><ix:nonFraction contextRef="C_GX_HZ" decimals="0" scale="0" unitRef="GBP" name="core:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantEquipment">800</ix:nonFraction></div><div class="crn fn1" style="top:401.9pt;left:417.68pt;width:49.71pt;"><ix:nonFraction contextRef="C" decimals="0" scale="0" unitRef="GBP" name="core:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantEquipment">800</ix:nonFraction></div><div class="cln fn0 sln" style="top:417.74pt;left:342.2pt;width:25.74pt;"></div><div class="cln fn0 sln" style="top:417.74pt;left:391.93pt;width:25.74pt;"></div><div class="cln fn0 sln" style="top:417.74pt;left:441.64pt;width:25.74pt;"></div><div class="cln fn1" style="top:423.91pt;left:67.73pt;width:250.5pt;">At 30 June 2019</div><div class="crn fn1" style="top:423.91pt;left:318.23pt;width:49.72pt;"><ix:nonFraction contextRef="B_GX_HY" decimals="0" scale="0" unitRef="GBP" name="core:PropertyPlantEquipmentGrossCost">789</ix:nonFraction></div><div class="crn fn1" style="top:423.91pt;left:367.95pt;width:49.72pt;"><ix:nonFraction contextRef="B_GX_HZ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">1,429</ix:nonFraction></div><div class="crn fn1" style="top:423.91pt;left:417.68pt;width:49.71pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">2,218</ix:nonFraction></div><div class="cln fn0 sln" style="top:439.75pt;left:342.2pt;width:25.74pt;"></div><div class="cln fn0 sln" style="top:439.75pt;left:391.93pt;width:25.74pt;"></div><div class="cln fn0 sln" style="top:439.75pt;left:441.64pt;width:25.74pt;"></div><div class="clb fn1" style="top:445.92pt;left:67.73pt;width:253.5pt;">Depreciation and impairment</div><div class="cln fn1" style="top:456.93pt;left:67.73pt;width:250.5pt;">At 1 July 2018</div><div class="crn fn1" style="top:456.93pt;left:318.23pt;width:49.72pt;"><ix:nonFraction contextRef="A_GX_HY" decimals="0" scale="0" unitRef="GBP" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">717</ix:nonFraction></div><div class="crn fn1" style="top:456.93pt;left:367.95pt;width:49.72pt;"><ix:nonFraction contextRef="A_GX_HZ" decimals="0" scale="0" unitRef="GBP" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">157</ix:nonFraction></div><div class="crn fn1" style="top:456.93pt;left:417.68pt;width:49.71pt;"><ix:nonFraction contextRef="A" decimals="0" scale="0" unitRef="GBP" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">874</ix:nonFraction></div><div class="cln fn1" style="top:467.93pt;left:67.73pt;width:250.5pt;">Depreciation charged in the year</div><div class="crn fn1" style="top:467.93pt;left:318.23pt;width:49.72pt;"><ix:nonFraction contextRef="C_GX_HY" decimals="0" scale="0" unitRef="GBP" name="core:IncreaseFromDepreciationChargeForYearPropertyPlantEquipment">18</ix:nonFraction></div><div class="crn fn1" style="top:467.93pt;left:367.95pt;width:49.72pt;"><ix:nonFraction contextRef="C_GX_HZ" decimals="0" scale="0" unitRef="GBP" name="core:IncreaseFromDepreciationChargeForYearPropertyPlantEquipment">318</ix:nonFraction></div><div class="crn fn1" style="top:467.93pt;left:417.68pt;width:49.71pt;"><ix:nonFraction contextRef="C" decimals="0" scale="0" unitRef="GBP" name="core:IncreaseFromDepreciationChargeForYearPropertyPlantEquipment">336</ix:nonFraction></div><div class="cln fn0 sln" style="top:483.78pt;left:342.2pt;width:25.74pt;"></div><div class="cln fn0 sln" style="top:483.78pt;left:391.93pt;width:25.74pt;"></div><div class="cln fn0 sln" style="top:483.78pt;left:441.64pt;width:25.74pt;"></div><div class="cln fn1" style="top:489.95pt;left:67.73pt;width:250.5pt;">At 30 June 2019</div><div class="crn fn1" style="top:489.95pt;left:318.23pt;width:49.72pt;"><ix:nonFraction contextRef="B_GX_HY" decimals="0" scale="0" unitRef="GBP" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">735</ix:nonFraction></div><div class="crn fn1" style="top:489.95pt;left:367.95pt;width:49.72pt;"><ix:nonFraction contextRef="B_GX_HZ" decimals="0" scale="0" unitRef="GBP" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">475</ix:nonFraction></div><div class="crn fn1" style="top:489.95pt;left:417.68pt;width:49.71pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">1,210</ix:nonFraction></div><div class="cln fn0 sln" style="top:505.79pt;left:342.2pt;width:25.74pt;"></div><div class="cln fn0 sln" style="top:505.79pt;left:391.93pt;width:25.74pt;"></div><div class="cln fn0 sln" style="top:505.79pt;left:441.64pt;width:25.74pt;"></div><div class="clb fn1" style="top:511.96pt;left:67.73pt;width:402.65pt;">Carrying amount</div><div class="cln fn1" style="top:522.97pt;left:67.73pt;width:250.5pt;">At 30 June 2019</div><div class="crn fn1" style="top:522.97pt;left:318.23pt;width:49.72pt;"><ix:nonFraction contextRef="B_GX_HY" decimals="0" scale="0" unitRef="GBP" name="core:PropertyPlantEquipment">54</ix:nonFraction></div><div class="crn fn1" style="top:522.97pt;left:367.95pt;width:49.72pt;"><ix:nonFraction contextRef="B_GX_HZ" decimals="0" scale="0" unitRef="GBP" name="core:PropertyPlantEquipment">954</ix:nonFraction></div><div class="crn fn1" style="top:522.97pt;left:417.68pt;width:49.71pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">1,008</ix:nonFraction></div><div class="cln fn0 dln" style="top:538.81pt;left:342.2pt;width:25.74pt;"></div><div class="cln fn0 dln" style="top:538.81pt;left:391.93pt;width:25.74pt;"></div><div class="cln fn0 dln" style="top:538.81pt;left:441.64pt;width:25.74pt;"></div><div class="cln fn1" style="top:544.98pt;left:67.73pt;width:250.5pt;">At 30 June 2018</div><div class="crn fn1" style="top:544.98pt;left:318.23pt;width:49.72pt;"><ix:nonFraction contextRef="E_GX_HY" decimals="0" scale="0" unitRef="GBP" name="core:PropertyPlantEquipment">72</ix:nonFraction></div><div class="crn fn1" style="top:544.98pt;left:367.95pt;width:49.72pt;"><ix:nonFraction contextRef="E_GX_HZ" decimals="0" scale="0" unitRef="GBP" name="core:PropertyPlantEquipment">472</ix:nonFraction></div><div class="crn fn1" style="top:544.98pt;left:417.68pt;width:49.71pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" name="core:PropertyPlantEquipment">544</ix:nonFraction></div><div class="cln fn0 dln" style="top:560.82pt;left:342.2pt;width:25.74pt;"></div><div class="cln fn0 dln" style="top:560.82pt;left:391.93pt;width:25.74pt;"></div><div class="cln fn0 dln" style="top:560.82pt;left:441.64pt;width:25.74pt;"></div><div class="clb fn1" style="top:578pt;left:46.61pt;width:24.12pt;">4</div><div class="clb fn1" style="top:578pt;left:67.73pt;width:174.54pt;">Debtors</div><div class="crb fn1" style="top:589pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn1" style="top:589pt;left:405.95pt;width:61.43pt;">2018</div><div class="clb fn1" style="top:600.01pt;left:67.73pt;width:174.54pt;">Amounts falling due within one year:</div><div class="crb fn1" style="top:600.01pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn1" style="top:600.01pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn6" style="top:600.01pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn1" style="top:622.02pt;left:67.73pt;width:284.66pt;">Trade debtors</div><div class="crn fn1" style="top:622.02pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TradeDebtorsTradeReceivables">31,585</ix:nonFraction></div><div class="crn fn1" style="top:622.02pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TradeDebtorsTradeReceivables">66,101</ix:nonFraction></div><div class="cln fn0 dln" style="top:637.87pt;left:383.21pt;width:25.74pt;"></div><div class="cln fn0 dln" style="top:637.87pt;left:441.64pt;width:25.74pt;"></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">LARKIN OPHTHALMOLOGY LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 6 -</div><div class="clb fn1" style="top:122.11pt;left:46.61pt;width:24.12pt;">5</div><div class="clb fn1" style="top:122.11pt;left:67.73pt;width:287.66pt;">Creditors: amounts falling due within one year</div><div class="crb fn1" style="top:133.12pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn1" style="top:133.12pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn1" style="top:144.12pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn1" style="top:144.12pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn6" style="top:144.12pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn1" style="top:166.14pt;left:67.73pt;width:228.1pt;">Corporation tax</div><div class="crn fn1" style="top:166.14pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CorporationTaxPayable">44,205</ix:nonFraction></div><div class="crn fn1" style="top:166.14pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CorporationTaxPayable">52,340</ix:nonFraction></div><div class="cln fn1" style="top:177.14pt;left:67.73pt;width:228.1pt;">Other taxation and social security</div><div class="crn fn1" style="top:177.14pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_HF_HN" decimals="0" scale="0" unitRef="GBP" name="core:OtherTaxationSocialSecurityPayable">474</ix:nonFraction></div><div class="crn fn1" style="top:177.14pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_HF_HN" decimals="0" scale="0" unitRef="GBP" name="core:OtherTaxationSocialSecurityPayable">450</ix:nonFraction></div><div class="cln fn1" style="top:188.15pt;left:67.73pt;width:228.1pt;">Other creditors</div><div class="crn fn1" style="top:188.15pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherCreditors">20,153</ix:nonFraction></div><div class="crn fn1" style="top:188.15pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherCreditors">19,742</ix:nonFraction></div><div class="cln fn1" style="top:199.16pt;left:67.73pt;width:228.1pt;">Accruals and deferred income</div><div class="crn fn1" style="top:199.16pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccruedLiabilitiesDeferredIncome">4,560</ix:nonFraction></div><div class="crn fn1" style="top:199.16pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccruedLiabilitiesDeferredIncome">4,459</ix:nonFraction></div><div class="cln fn0 sln" style="top:215pt;left:383.21pt;width:25.74pt;"></div><div class="cln fn0 sln" style="top:215pt;left:441.64pt;width:25.74pt;"></div><div class="crn fn1" style="top:221.17pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">69,392</ix:nonFraction></div><div class="crn fn1" style="top:221.17pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_HF_HN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">76,991</ix:nonFraction></div><div class="cln fn0 dln" style="top:237.02pt;left:383.21pt;width:25.74pt;"></div><div class="cln fn0 dln" style="top:237.02pt;left:441.64pt;width:25.74pt;"></div><div class="clb fn1" style="top:254.19pt;left:46.61pt;width:24.12pt;">6</div><div class="clb fn1" style="top:254.19pt;left:67.73pt;width:287.66pt;">Called up share capital</div><div class="crb fn1" style="top:265.19pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn1" style="top:265.19pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn1" style="top:276.2pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn1" style="top:276.2pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn6" style="top:276.2pt;left:468.03pt;width:0.65pt;"></div><div class="clb fn1" style="top:287.21pt;left:67.73pt;width:287.66pt;">Ordinary share capital</div><div class="clb fn1" style="top:298.21pt;left:67.73pt;width:400.78pt;">Issued and fully paid</div><div class="cln fn1" style="top:309.22pt;left:67.73pt;width:228.1pt;">100 Ordinary Shares of £1 each</div><div class="crn fn1" style="top:309.22pt;left:352.39pt;width:56.56pt;">100</div><div class="crn fn1" style="top:309.22pt;left:408.95pt;width:58.43pt;">100</div><div class="cln fn0 dln" style="top:325.07pt;left:383.21pt;width:25.74pt;"></div><div class="cln fn0 dln" style="top:325.07pt;left:441.64pt;width:25.74pt;"></div><div class="clb fn1" style="top:342.24pt;left:46.61pt;width:24.12pt;">8</div><div class="clb fn1" style="top:342.24pt;left:67.73pt;width:402.65pt;">Directors' transactions</div><div class="cln" style="top:364pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Dividends totalling £90,000 (2018 - £120,000) were paid in the year in respect of shares held by the company&apos;s directors.</span></p></div><div class="cln" style="top:396pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">As at the yea end the company owed the director £</span><span class="fn1">20,021</span><span class="fn1"> (201</span><span class="fn1">8</span><span class="fn1"> - £</span><span class="fn1">19,742</span><span class="fn1">).</span></p></div></div><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="B" name="bus:EndDateForPeriodCoveredByReport">2019-06-30</ix:nonNumeric><ix:nonNumeric contextRef="B" name="bus:StartDateForPeriodCoveredByReport">2018-07-01</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:EntityDormantTruefalse">false</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:EntityTradingStatus"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:NameProductionSoftware">CCH Software</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:VersionProductionSoftware">CCH Accounts Production 2019.200</ix:nonNumeric><ix:nonNumeric contextRef="C_IC_ID" name="bus:LegalFormEntity"></ix:nonNumeric><ix:nonNumeric contextRef="C_IE_IF" name="bus:AccountingStandardsApplied"></ix:nonNumeric><ix:nonNumeric contextRef="C_IG_IH" name="bus:AccountsStatusAuditedOrUnaudited"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:DescriptionPrincipalActivities">No description of principal activity</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:ScopeAccounts"></ix:nonNumeric><ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="aurep:DateAuditorsReport">16 March 2020</ix:nonNumeric><ix:nonNumeric contextRef="C_IJ_IK" name="bus:ApplicableLegislation"></ix:nonNumeric><ix:nonNumeric contextRef="C_HR_HS" name="bus:NameEntityOfficer">Mr D F P Larkin</ix:nonNumeric><ix:nonNumeric contextRef="C_HR_IL" name="bus:NameEntityOfficer">Mrs Catherine Larkin</ix:nonNumeric><ix:nonNumeric contextRef="C_IM_IN" name="bus:AccountsTypeFullOrAbbreviated"></ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.frc.org.uk/FRS-102/2014-09-01/FRS-102-2014-09-01.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="B"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_GX_HY"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:FurnitureFittings</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_GX_HZ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:ComputerEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_GX_HY"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:FurnitureFittings</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_GX_HZ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:ComputerEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_HF_HN"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_HF_HN"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_HO_HP"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapital</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_HO_HP"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapital</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_HO_HQ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:RetainedEarningsAccumulatedLosses</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_HO_HQ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:RetainedEarningsAccumulatedLosses</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_HR_HS"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_HU_HV"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:IntangibleAssetClassesDimension">core:Goodwill</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_GX_HY"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:FurnitureFittings</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_GX_HZ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:ComputerEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="A_GX_HY"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:FurnitureFittings</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="A_GX_HZ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:ComputerEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="A"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_IC_ID"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:LegalFormEntityDimension">bus:PrivateLimitedCompanyLtd</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_IE_IF"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountingStandardsDimension">bus:FRS102</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_IG_IH"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountsStatusDimension">bus:AuditExemptWithAccountantsReport</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_IJ_IK"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:ApplicableLegislationDimension">bus:SmallCompaniesRegimeForAccounts</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_HR_IL"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director2</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_IM_IN"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07199788</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountsTypeDimension">bus:FullAccounts</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="GBP"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit></ix:resources></ix:header></div></body></html>